A Phase 2b double-blind randomized placebo-controlled study of RVT-101 in subjects with dementia with Lewy bodies (DLB)
J
Jared Brosch, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Overview
The purpose of this study is to investigate how well RVT-101 works to improve cognitive and overall function as well as to investigate the safety of RVT-101.
Description
The purpose of this study is to test PVT-101 to evaluate whether it can help cognition and overall function in subjects with dementia with Lewy bodies.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
dementia
-
Age: Between 50 Years - 85 Years
-
Gender: All
Updated on
19 Apr 2024.
Study ID: 1603122491
